Samsung Eyes Investment in Exo's $100M Funding Round
Samsung Ventures is considering a substantial investment in Exo, a California-based startup known for its portable ultrasound devices. This potential investment is part of a $100 million funding round, which is being led by Sands Capital, Bold Capital, and Qubit Health Capital, reports TechCrunch.
Exo, founded in 2015, develops handheld medical imaging devices that integrate artificial intelligence, medical imaging, and silicon technology. These devices connect to smartphones, allowing medical professionals to conduct ultrasound examinations and share results via a mobile app. The company has already raised over $320 million from investors such as RA Capital Management, BlackRock, Intel, and Sony.
In addition to the investment, Exo is in discussions with Samsung Medison Co., a subsidiary of Samsung specializing in medical ultrasound and digital radiography systems, to explore potential partnerships.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like AI Funding Brief, Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Funding
Oct 16 Intuit Agrees to Acquire AI Billing Startup Sequence for Reported $200 Million Oct 16 Matters Raises $5 Million to Build AI Consumer Bank Oct 16 KP Labs raises €4.42 million for AI data processing in orbit Oct 15 Origin Raises $20 Million for Autonomous Construction Robots Oct 15 Symbe Raises $5.7 Million for AI Sales PlatformMore from Life Sciences
Oct 16 Study Tests Smartphone AI for Children's Lung Sounds Oct 16 Manhattan Physician Invests in RunPractice Oct 16 Attilio appoints Buck Institute CEO Eric Verdin as cochairman Oct 16 Aignostics launches HETA Clinical for pathology workflows Oct 16 Specialty1 Partners Invests in AI for Dental Practice OperationsLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
HealthpointCapital Invests in Surgical Software Company Ospitek
DeepSight Technology Adds Scott Huennekens to Board
Expanse Raises $5.3 Million for AI Compute Planning Software
Nexstrom Raises $12 Million for 12 Inch Semiconductor Wafer Platform
DeepSeek Reportedly Agrees to Lead Winverse AI Seed Round
Daily AI Brief: the AI news that matters, in your inbox.